Ketral Adverse Reactions

The following adverse reactions were reported to be probably related to ketorolac tromethamine in patients which received up to 20 doses in up to 5 days of IM administered ketorolac tromethamine 30 mg and in patients which received up to 8 doses in 2 days of IV administered ketorolac tromethamine 30 mg.
Incidence between 3 and 9%: Gastrointestinal: Nausea, dyspepsia, gastrointestinal pain.
Central nervous system: Drowsiness.
Incidence between 1 and 3%: Gastrointestinal: Diarrhoea.
Central Nervous system: Dizziness, headache, sweating.
Body as a whole: Edema.
Injection site pain was reported by 2% of patient.
Incidence 1% or less: Gastrointestinal: Constipation, flatulence, gastrointestinal fullness, liver function abnormalities, melena, peptic ulcer, rectal bleeding, stomatitis, vomiting.
Body as a whole: Asthenia, myalgia.
Cardiovascular: Flushing, pallor.
Hemic and lymphatic: Purpura.
Nervous system: Dry mouth, nervousness, paraesthesia, abnormal thinking, depression, euphoria, excessive thirst, inability to concentrate, insomnia, stimulation, vertigo.
Respiratory: Dyspnea, asthma.
Urogenital: Increased urinary frequency, oliguria.
Dermatologic: Pruritus, urticaria.
Special senses: Abnormal taste, abnormal vision.